Low-dose atropine eye drops for excessive tearing
Part of Eyes & vision clinical trials.
This study tests whether low-dose atropine eye drops, given nightly for 7 days, can reduce excessive tearing (epiphora) in adults. If you have bothersome tearing not caused by dry eyes, this treatment might offer relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Have excessive tearing that makes you wipe or dab your eyes at least twice a day
- Tearing is not due to dry eyes or other eye surface problems
- Not currently using artificial tears or eye lubricants, and willing to stop them during the study
- Willing to self-administer eye drops nightly for 7 days in two separate periods
- No history of angle-closure glaucoma or narrow anterior chamber angles
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies whether numbing eye drops (proparacaine 0.5%) can reduce pain during a procedure called probing and irrigation of the tear drainage system. If you need this test for ongoing watery eyes, the trial may help make the procedure more comfortable.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This study tests a new eye drop (oxymetazoline) to see if it can help lift droopy eyelids in adults. To join, you must have a certain amount of eyelid droop and some vision loss in your upper field of view, and you should feel that the droop bothers you enough to want treatment.
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Hear when a new Epiphora trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.